The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Agresta Samuel since 2023.
This trader's CIK number is 1748961.
At the time of last reporting, Agresta Samuel was the Chief Medical Officer of Foghorn Therapeutics Inc.. (stock ticker symbol FHTX).
Also see all insider trading activities at Foghorn Therapeutics Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | FHTX | 0 | $0 | 311,297 | $2,568,200 | 311,297 | $1,158,024 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-08-16 | FHTX | Sale | 311,297 | 8.25 | 2,568,200 |
| 2023-08-16 | FHTX | Option Ex | 311,297 | 3.72 | 1,158,024 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Agresta Samuel (Chief Medical Officer of Foghorn Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.